UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The last round about statins: there is the fact that 80 mg simvastatin daily results in high risk of myopathy

Läkartidningen, 2009-10, Vol.106 (43), p.2783

Olsson, Anders G

2009

Volltextzugriff (PDF)

Resistance against tyrosine kinase inhibitors in the treatment of GIST. New therapeutic possibilities appear

Läkartidningen, 2009-12, Vol.106 (50-51), p.3424-3429

2009

Volltextzugriff (PDF)

Pfizer: TLV decision about antilipemic agents is founded on wrong basis

Läkartidningen, 2009-04, Vol.106 (17), p.1193-4; discussion 1194

2009

Volltextzugriff (PDF)

High-dose statin in ischemic stroke reduces the risk of recurrent stroke

Läkartidningen, 2008-11, Vol.105 (48-49), p.3541-3543

2008

Volltextzugriff (PDF)

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)

Diabetes care, 2005-05, Vol.28 (5), p.1151-1157

2005

Volltextzugriff (PDF)

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

The Lancet (British edition), 2017-07, Vol.390 (10093), p.457-468

2017

Volltextzugriff (PDF)

Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study

Cancer discovery, 2022-02, Vol.12 (2), p.402-415

2022

Volltextzugriff (PDF)

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2018-04, Vol.378 (14), p.1277-1290

2018

Volltextzugriff (PDF)

Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial

British journal of dermatology (1951), 2016-11, Vol.175 (5), p.902-911

2016

Volltextzugriff (PDF)

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

The lancet oncology, 2020-05, Vol.21 (5), p.671-684

2020

Volltextzugriff (PDF)

Convincing evidence from controlled and uncontrolled studies on the lipid-lowering effect of a statin

Cochrane database of systematic reviews, 2012-12 (12), p.ED000049

Higgins, Julian

2012

Volltextzugriff (PDF)

Atogepant for the Preventive Treatment of Migraine

The New England journal of medicine, 2021-08, Vol.385 (8), p.695-706

2021

Volltextzugriff (PDF)

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors

The New England journal of medicine, 2017-10, Vol.377 (16), p.1525-1536

2017

Volltextzugriff (PDF)

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

Arthritis research & therapy, 2019-04, Vol.21 (1), p.89-18, Article 89

2019

Volltextzugriff (PDF)

Acid‐inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects ‐ a randomised open‐label cross‐over study

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (6), p.719-730

2015

Volltextzugriff (PDF)

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial

Journal of clinical oncology, 2017-02, Vol.35 (6), p.591-597

2017

Volltextzugriff (PDF)

Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan

Gut, 2020-06, Vol.69 (6), p.1019-1026

2020

Volltextzugriff (PDF)

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study

Gut, 2016-09, Vol.65 (9), p.1439-1446

2016

Volltextzugriff (PDF)

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

The New England journal of medicine, 2016-12, Vol.375 (23), p.2246-2254

2016

Volltextzugriff (PDF)

A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

Blood, 2018-01, Vol.131 (4), p.387-396

2018

Volltextzugriff (PDF)

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

Nature medicine, 2021-12, Vol.27 (12), p.2183-2191

2021

Volltextzugriff (PDF)

Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis

The New England journal of medicine, 2017-10, Vol.377 (16), p.1537-1550

2017

Volltextzugriff (PDF)

Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study

Arthritis & rheumatology (Hoboken, N.J.), 2013-03, Vol.65 (3), p.559-570

2013

Volltextzugriff (PDF)

Tofacitinib versus Methotrexate in Rheumatoid Arthritis

The New England journal of medicine, 2014-06, Vol.370 (25), p.2377-2386

2014

Volltextzugriff (PDF)

1 – 25 von 4.032

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.780)
Mit Volltextzugriff
(3.316)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.421)
Life Sciences & Biomedicine
(3.290)
Humans
(3.136)
Pyrroles - Administration & Dosage
(2.997)
Male
(2.559)
Female
(2.175)
Middle Aged
(1.623)
Heptanoic Acids - Administration & Dosage
(1.348)
Animals
(1.319)
Atorvastatin Calcium
(1.213)
Aged
(1.209)
Biological And Medical Sciences
(1.068)
Adult
(1.066)
Medical Sciences
(1.023)
Pyrroles - Therapeutic Use
(996)
Treatment Outcome
(993)
Indoles - Administration & Dosage
(912)
Pyrroles - Pharmacology
(832)
Oncology
(825)
Pyrroles - Adverse Effects
(777)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(4.024)
Ingenta
(1.901)
EZB Electronic Journals Library
(1.849)
Ovid
(1.793)
Elsevier ScienceDirect Journals Complete
(902)
Standalone journals
(800)
IngentaConnect Journals
(743)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(650)
Springer journals
(563)
Wiley-Blackwell Journals (Backfile Content)
(534)
Wiley Online Library Full Collection 2018
(395)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(303)
Taylor & Francis Journals Auto-Holdings Collection
(169)
Taylor & Francis
(168)
Oxford University Press Journals Current
(147)
Taylor & Francis Online
(136)
Nexis Uni
(131)
Nature
(128)
Oxford Journals 2020 Medicine
(100)
SAGE Complete
(92)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(25)

Menü

Weitere Dienste

Einstellungen

The last round about statins: there is the fact that 80 mg simvastatin daily results in high risk of myopathy

Resistance against tyrosine kinase inhibitors in the treatment of GIST. New therapeutic possibilities appear

Pfizer: TLV decision about antilipemic agents is founded on wrong basis

High-dose statin in ischemic stroke reduces the risk of recurrent stroke

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

Convincing evidence from controlled and uncontrolled studies on the lipid-lowering effect of a statin

Atogepant for the Preventive Treatment of Migraine

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

Acid‐inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects ‐ a randomised open‐label cross‐over study

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial

Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis

Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study

Tofacitinib versus Methotrexate in Rheumatoid Arthritis

Suchergebnisse filtern